Université de Paris, CRESS, INSERM, INRAE, F-75004Paris, France.
National Institute of Health and Medical Research (INSERM), UMR INSERM NeuroDiderot, DHU Protect, F-75019Paris, France.
J Dev Orig Health Dis. 2021 Oct;12(5):704-713. doi: 10.1017/S2040174420001051. Epub 2020 Dec 10.
Women with thyroid diseases at the beginning of pregnancy may have suboptimal thyroid hormone levels because of potential difficulties in compensating for the physiological thyroid hormone changes occurring in pregnancy. Our objective was to study the association between preexisting thyroid diseases, pregnancy complications, and neonatal anthropometry. In total, 16,395 women from the ELFE French longitudinal birth cohort were included, and 273 declared pre-pregnancy thyroid diseases. Associations were investigated with multivariable regression models, with adjustment for relevant potential confounders. Body mass index (BMI) was additionally adjusted for in a second stage. As compared with other women, women with pre-pregnancy thyroid diseases were more frequently obese (19.6% vs. 9.8%) and had greater odds of gestational diabetes development (odds ratio [OR] = 1.58 [95% confidence interval [CI] 1.08, 2.30]) or had undergone treatment for infertility (OR = 1.57 [95% CI 1.07, 2.31]). After adjustment for BMI, the association with gestational diabetes was no longer significant (OR = 1.27 [95% CI 0.86, 1.88]). After excluding women with another medical history, those with pre-pregnancy thyroid diseases had increased odds of premature rupture of membranes (OR = 1.51 [95% CI 1.01, 2.25]). Children born from mothers with hypothyroidism before conception due to a disease or as a potential side effect of treatment had a smaller head circumference at birth than other children (β = -0.23 [95% CI -0.44, -0.01] cm). In conclusion, pre-pregnancy thyroid diseases were associated with risk of infertility treatment, gestational diabetes, and premature rupture of membranes. The association between history of hypothyroidism and moderate adverse effects on fetal head circumference growth needs replication.
孕妇在妊娠初期可能由于难以代偿妊娠时甲状腺激素的生理性变化,而出现甲状腺激素水平不理想。我们的研究目的是探讨孕前甲状腺疾病、妊娠并发症与新生儿体格发育之间的关系。共纳入了法国 ELFE 纵向出生队列中的 16395 名女性,其中 273 名女性在孕前患有甲状腺疾病。通过多变量回归模型进行相关性分析,并调整了相关潜在混杂因素。在第二阶段,还对体重指数(BMI)进行了调整。与其他女性相比,患有孕前甲状腺疾病的女性更常肥胖(19.6% vs. 9.8%),且发生妊娠期糖尿病的风险更高(比值比[OR] = 1.58 [95%置信区间[CI] 1.08, 2.30]),或接受过不孕治疗(OR = 1.57 [95% CI 1.07, 2.31])。调整 BMI 后,与妊娠期糖尿病的相关性不再显著(OR = 1.27 [95% CI 0.86, 1.88])。排除有其他病史的女性后,患有孕前甲状腺疾病的女性胎膜早破的风险更高(OR = 1.51 [95% CI 1.01, 2.25])。由于疾病或治疗的潜在副作用,在受孕前患有甲状腺功能减退症的女性所生的婴儿,其出生时头围较小(β = -0.23 [95% CI -0.44, -0.01]cm)。总之,孕前甲状腺疾病与不孕治疗、妊娠期糖尿病和胎膜早破的风险增加相关。甲状腺功能减退症病史与胎儿头围生长的中度不良影响之间的关联需要进一步研究。